Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study was terminated in the United States. It is testing Multiple Rising Doses of TAK-137 for ADHD.
In United StatesThis study is completed in the United States. It is testing OMS643762 for schizophrenia.
In United StatesThis study is completed in the United States. It is testing Single Doses of APN1125 for Schizophrenia.
In United StatesThis study is completed in the United States. It focuses on Schizophrenia.
Remote / onlineThis study is completed in the United States. It is testing elpipodect for schizophrenia.
In United StatesThis study is completed in the United States. It is testing SPD489 for ADHD.
In United StatesThis study is completed in the United States. It focuses on Schizophrenia.
In United StatesThis study is completed in the United States. It focuses on ADHD.
In United States
This summary needs review. Please check the official study record and contact the research team for details.
In United States
This summary needs review. Please check the official study record and contact the research team for details.
In United StatesThis summary needs review. Please check the official study record and contact the research team for details.
In United StatesThis study exists to see whether a digital app or remote support tool is workable and worth testing more broadly. Researchers are trying to understand how people respond to a digital app or remote support tool in practice and what may need to be adjusted.
Remote / onlineHopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.